Efficacy of the Priority Review Voucher Program
JAMA
.
2016 Apr 19;315(15):1659-60.
doi: 10.1001/jama.2016.0377.
Authors
David B Ridley
1
,
Jennifer Dent
2
,
Christopher Egerton-Warburton
3
Affiliations
1
Duke University, Durham, North Carolina.
2
BIO Ventures for Global Health, Seattle, Washington.
3
Lion's Head Global Partners, London, United Kingdom.
PMID:
27092837
DOI:
10.1001/jama.2016.0377
No abstract available
Publication types
Letter
Comment
MeSH terms
Drug Approval / economics*
Drug Industry / economics*
Humans
Neglected Diseases / drug therapy*
Program Development / economics*
Rare Diseases / drug therapy*